Showing results (21-30 of 550) with videos related to
Sort By:
Pageof 55
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
The Translational Research Working Group developmental pathway for interventive devicesGary S Dorfman, Theodore S Lawrence, Lynn M Matrisian, et al.The Lancet. Oncology|January 5, 2005
Radiotherapy: what can be achieved by technical improvements in dose delivery?Jean M Moran, Mohamed A Elshaikh, Theodore S LawrenceSeminars in Surgical Oncology|December 4, 2003
Conformal chemoradiation for primary and metastatic liver malignanciesLaura A Dawson, Cornelius J McGinn, Theodore S LawrenceRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 25, 2017
Blood-tumor barrier opening changes in brain metastases from pre to one-month post radiation therapyFeifei Teng, Christina I Tsien, Theodore S Lawrence, et al.International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Identification of peptides that bind to irradiated pancreatic tumor cellsCanhui Huang, Xiang Y Liu, Alnawaz Rehemtulla, et al.Medical Physics|January 7, 2014
DCE-MRI defined subvolumes of a brain metastatic lesion by principle component analysis and fuzzy-c-means clustering for response assessment of radiation therapyReza Farjam, Christina I Tsien, Theodore S Lawrence, et al.Cancer Control : Journal of the Moffitt Cancer Center|April 1, 2008
The use of blood biomarkers to predict radiation lung toxicity: a potential strategy to individualize thoracic radiation therapyFeng-Ming Kong, Xiaoping Ao, Li Wang, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 31, 2005
Determination of WR-1065 in human blood by high-performance liquid chromatography following fluorescent derivatization by a maleimide reagent ThioGlo3Jun Chen, Zheng Lu, Theodore S Lawrence, et al.JCO Clinical Cancer Informatics|November 2, 2020
Characterization of the Tumor Immune Microenvironment Identifies M0 Macrophage-Enriched Cluster as a Poor Prognostic Factor in Hepatocellular CarcinomaMark Farha, Neil K Jairath, Theodore S Lawrence, et al.Cancer Discovery|February 20, 2014
Improving the efficacy of chemoradiation with targeted agentsMeredith A Morgan, Leslie A Parsels, Jonathan Maybaum, et al.Pageof 55